CINDY BURGAMY-STEVENS NP
Prescription History 1205800984
Nurse Practitioner in Madera, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CINDY BURGAMY-STEVENS NP, an active Nurse Practitioner specialist practicing in Madera, CA. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 64 documented patient claims. Among these therapy options, the most frequently utilized medication is Sulfamethoxazole-Trimethoprim, which accounts for 27 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs CA Avg |
|---|---|---|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | 27.0 | 195 | $5.56▼ below CA avg | ≈ Typical |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average This provider's average cost per claim is below the CA average for this medication. 27.0 30-Day Fills 195 Days Supply About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. | |||||
| Azithromycin | 21 | 21.0 | 104 | $6.96▼ below CA avg | ▼ Below Avg. |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average This provider's average cost per claim is below the CA average for this medication. 21.0 30-Day Fills 104 Days Supply About Azithromycin: This medication is used to treat certain eye infections. Show more ▾ It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. | |||||
| Ciprofloxacin Hcl | 16 | 16.0 | 130 | $10.77 | ▼ Below Avg. |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average Gross Part D cost per claim; not the patient's out-of-pocket price. 16.0 30-Day Fills 130 Days Supply About Ciprofloxacin Hcl: This medication is used to treat eye infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A broad-spectrum antimicrobial carboxyfluoroquinoline. | |||||
About this data. The prescription history for CINDY BURGAMY-STEVENS NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Madera, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
